Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 15
The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review
Taraneh Hoseinnezhad, Nasrin Soltani, Sarina Ziarati, et al.
Journal of Clinical Laboratory Analysis (2024) Vol. 38, Iss. 1-2
Open Access | Times Cited: 12
Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV
Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study
Amita Ketkar, Vincent J. Willey, Michael Pollack, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 8, pp. 1103-1118
Open Access | Times Cited: 20
HIV-associated lung disease
Ioannis Konstantinidis, Kristina Crothers, Ken M. Kunisaki, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 16
The effect of macronutrient and micronutrient supplements on COVID-19: an umbrella review
SeyedAhmad SeyedAlinaghi, Ramin Shahidi, Hengameh Mojdeganlou, et al.
Journal of Health Population and Nutrition (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Roland Linder, Jonas Peltner, A. Astvatsatourov, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 25
The Impact of COVID-19 Pandemic on the Levels of Physical Activity: A Systematic Review
Esmaeil Mehraeen, Amirali Karimi, Peyman Mirghaderi, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 15
Resveratrol and Gut Microbiota Synergy: Preventive and Therapeutic Effects
Miloš Gostimirović, Jovana Rajković, Ana Bukarica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17573-17573
Open Access | Times Cited: 9
Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
Tatjana T. Makovski, Jinane Ghattas, Stéphanie Monnier-Besnard, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 3
A Digital Health Initiative (COVIDsmart) for Remote Data Collection and Study of COVID-19’s Impact on the State of Virginia: Prospective Cohort Study
Josh Schilling, Dave Klein, Marilyn M. Bartholmae, et al.
JMIR Formative Research (2023) Vol. 7, pp. e37550-e37550
Open Access | Times Cited: 8
SARS-CoV-2 Infection during Delivery Causes Histopathological Changes in the Placenta
Jędrzej Borowczak, Agnieszka Gąsiorek-Kwiatkowska, Krzysztof Szczerbowski, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 142-142
Open Access | Times Cited: 2
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Lung infections in immunocompromised children
Alistair Calder, Giulia Perucca, Sarah Johnson, et al.
Pediatric Radiology (2023) Vol. 54, Iss. 4, pp. 530-547
Closed Access | Times Cited: 5
Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
Philippe Halfon, Sylvie Jordana, Stéphane Blachier, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0281257-e0281257
Open Access | Times Cited: 5
New primary immunodeficiencies 2023 update
Joyce E. Yu
Current Opinion in Pediatrics (2023) Vol. 36, Iss. 1, pp. 112-123
Closed Access | Times Cited: 5
Estimating Hidden Population Size of COVID-19 using Respondent-Driven Sampling Method - A Systematic Review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Mohsen Dashti, et al.
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 1
Prognostic indicators for hospitalization and ICU admission in people with multiple sclerosis and COVID-19: an analysis of the COVID-19 in MS global data sharing initiative dataset
Maria A. García‐Dominguez, Vincent Kipkorir, Bahadar S. Srichawla
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 720-725
Open Access | Times Cited: 1
Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination
Saishravan Shyamsundar, Sheila K. Pierson, Caoilfhionn M Connolly, et al.
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 1
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
Interferon-I Modulation and Natural Products: Unraveling Mechanisms and Therapeutic Potential in Severe COVID-19
Yuheng Song, Jiani Lu, Pengcheng Qin, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 1
Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection
Behram Ali Khan, Marlyn Pagsinohin, Lucy M. Lu, et al.
Cureus (2023)
Open Access | Times Cited: 3
The Impact of COVID-19 Infection Control Measures on End-Stage Renal Disease Patients in a Community Hemodialysis Setting
Behram Ali Khan, Rajat Tagore, Shilpa Rastogi, et al.
Cureus (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top